BackTable / Urology / Topic / Specialization
Urologic Oncology
Learn more on the BackTable Urology Podcast
BackTable is a knowledge resource for physicians by physicians. Get practical advice on Urologic Oncology and how to build your practice by listening to the BackTable Urology Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Urologic Oncology Podcasts
Listen to leading physicians discuss urologic oncology on the BackTable Urology Podcast. Get tips, tricks, and expert guidance from your peers and level up your practice.
Episode #178
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros Grivas from Fred Hutchinson Cancer Center and Dr. Sumanta (Monty) Pal from City of Hope.
Episode #172
In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.
Episode #170
In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).
Episode #161
This week on BackTable Urology, Dr. Suzette Sutherland (University of Washington) and Dr. Drew Peterson (Duke University) explore the psychological and clinical challenges faced by genitourinary cancer survivors dealing with the urological consequences of cystectomy and urinary diversion.
Episode #149
This week on BackTable Urology, urologic oncologist Dr. Bogdana Schmidt (University of Utah) hosts a discussion with medical oncology experts Dr. Rana McKay (UC San Diego) and Dr. Neeraj Agarwal (University of Utah) on recent clinical trials from bladder, kidney, and prostate cancer research presented at the 2023 European Society for Medical Oncology (ESMO) Meeting.
Episode #123
This week on BackTable Urology, Dr. Juan Javier-Desloges, a urologic oncologist at UC San Diego, interviews Dr. Neil Taunk, a radiation oncologist leading the Brachytherapy and Procedural Radiation program at the University of Pennsylvania, about his experience with using SpaceOAR rectal spacer for prostate cancer radiotherapy.
Urologic Oncology Articles
Read our exclusive BackTable Urology Articles for quick insights on urologic oncology, provided by physicians for physicians.
A variety of prostate cancer screening tools can be used to aid in patient selection for biopsy, in addition to guiding prostate cancer risk stratification. Urologists Dr. Jose Silva and Dr. Ali Kasraeian detail the role of multiparametric MRI and molecular testing in the early detection of prostate cancer.
The digital rectal exams and PSA blood tests both possess limitations as prostate cancer screening tools. Urologists Dr. Jose Silva and Dr. Ali Kasraeian share insight on society guidelines and research for PSA screening, decision-making, and patient education through a detailed risk-benefit analysis of prostate cancer detection.
BCG-unresponsive bladder cancer has distinct criteria for diagnosis and management. Official FDA diagnosis requires the development or recurrence of a high-grade bladder tumor after a patient has received adequate BCG therapy. Treatment duration varies based on whether an induction or maintenance course is indicated.
Disclaimer: The Materials available on https://www.BackTable.com/ are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.